The Effects of Pythagorean Self--Awareness Intervention on Irritable Bowel Syndrome Patients: A Non-randomized Controlled Trial

被引:0
|
作者
Gorgili, Kleopatra [1 ]
Artemiadis, Artemios [2 ]
Bacopoulou, Flora [3 ,4 ]
Karatzas, Pantelis [5 ]
Tigani, Xanthi [1 ]
Vlachakis, Dimitrios [6 ]
Kokka, Ioulia [1 ]
Varvogli, Liza [1 ]
Chrousos, George P. [3 ,4 ]
Darviri, Christina [3 ]
机构
[1] Natl & Kapodistrian Univ Athens, Sch Med, Postgrad Course Sci Stress & Hlth Promot, Athens, Greece
[2] Univ Cyprus, Med Sch, Nicosia, Cyprus
[3] Natl & Kapodistrian Univ Athens, Sch Med, Athens, Greece
[4] Natl & Kapodistrian Univ Athens, Univ Res Inst Maternal & Child Hlth & Precis Med, Aghia Sophia Childrens Hosp, UNESCO Chair Adolescent Hlth Care, Athens, Greece
[5] Natl & Kapodistrian Univ Athens, Laiko Gen Hosp, Med Sch, Athens, Greece
[6] Agr Univ Athens, Sch Appl Biol & Biotechnol, Dept Biotechnol, Lab Genet, Athens, Greece
来源
GENEDIS 2020: GERIATRICS | 2021年 / 1337卷
关键词
FUNCTIONAL GASTROINTESTINAL DISORDERS; ALTERNATIVE MEDICINE; COHERENCE; IMPACT; SENSE; ANGER; COMPLEMENTARY; PREVALENCE; DEPRESSION; NETWORK;
D O I
10.1007/978-3-030-78771-4_39
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder that affects a considerable percentage of the global population, mainly middle-aged women. IBS causes a constellation of symptoms with repercussions on patients' physical, psychological, and social well-being. Stress seems to play an important role in the pathogenesis of the disease as well as in its management. This study evaluated the effects of a novel non-pharmacological 8-week stress management intervention, the Pythagorean Self-Awareness Intervention (PSAI), in patients with IBS. In this non-randomized controlled trial, 60 IBS patients were assigned to an intervention and a control group. Self-reported questionnaires were used for the evaluation of IBS symptoms and a variety of biopsychological characteristics, pre- and post-intervention. All IBS-related symptoms were significantly reduced in the intervention group compared to the control group with 50% of the patients in the intervention group reporting less abdominal pain. The most potent effects of the intervention were observed in anger externalization, anger control, visuospatial memory, information processing speed, verbal memory, sense of coherence, stress, anxiety, and anger internalization. No side effects in the PSAI group were noted. In conclusion, PSAI was beneficial for patients suffering from IBS. Future research should expand and validate the results of this study.
引用
收藏
页码:345 / 354
页数:10
相关论文
共 50 条
  • [11] Efficacy of acupuncture in refractory irritable bowel syndrome patients: a randomized controlled trial
    Zhao, Jun
    Zheng, Hui
    Wang, Xin
    Wang, Xuefei
    Shi, Yunzhou
    Xie, Chaorong
    Tao, Qingfeng
    Li, Da
    Sun, Jingwen
    Tian, Junjian
    Gao, Junxia
    Liu, Huimin
    Shi, Suhua
    Ni, Jinxia
    Xue, Rongdan
    Hu, Hui
    Chen, Min
    Yu, Shuguang
    Li, Zhigang
    FRONTIERS OF MEDICINE, 2024, 18 (04) : 678 - 689
  • [12] Effect of autogenic training in patients with irritable bowel syndrome: A randomized controlled trial
    Shinozaki, Masae
    Kanazawa, Motoyori
    Kano, Michiko
    Endo, Yuka
    Hongo, Michio
    Fukudo, Shin
    GASTROENTEROLOGY, 2006, 130 (04) : A502 - A502
  • [13] The Role of Pythagorean Self-Awareness Intervention in Obstructive Sleep Apnea. A Randomized Controlled Trial
    Miskedaki, Anastasia
    Vagiakis, Emmanouil
    Bacopoulou, Flora
    Vlachakis, Dimitrios
    Artemiadis, Artemios
    Chrousos, George P.
    Darviri, Christina
    GENEDIS 2020: GERIATRICS, 2021, 1337 : 83 - 87
  • [14] Effects of Ramosetron on Male Patients With Irritable Bowel Syndrome With Diarrhea: Randomized, Placebo-Controlled Trial
    Fukudo, Shin
    Ida, Motoko
    Akiho, Hikaru
    Nakashima, Yoshihiro
    Matsueda, Kei
    GASTROENTEROLOGY, 2013, 144 (05) : S545 - S545
  • [15] Moxibustion intervention for patients with irritable bowel syndrome: A study protocol for a randomised controlled trial
    Kim, Taein
    Lee, Jaejun
    Chung, Jiwon
    Bae, Seungwon
    Kim, Jiyu
    Lee, Ju Ah
    Youn, Sang Jun
    Go, Ho-Yeon
    Shin, Seon-Mi
    EUROPEAN JOURNAL OF INTEGRATIVE MEDICINE, 2017, 9 : 126 - 130
  • [16] Mediational Analysis of Emotional Awareness and Expression Training for Patients with Irritable Bowel Syndrome: A Randomized Trial
    Thakur, Elyse R.
    Holmes, Hannah J.
    Lockhart, Nancy A.
    Carty, Jennifer N.
    Ziadni, Maisa S.
    Doherty, Heather
    Lackner, Jeffrey M.
    Schubiner, Howard
    Lumley, Mark A.
    GASTROENTEROLOGY, 2016, 150 (04) : S694 - S694
  • [17] Randomized Placebo Controlled Mulicenter Trial of Mesalazine in Patients With Irritable Bowel Syndrome (IBS)
    Barbara, Giovanni
    Cremon, Cesare
    Bellacosa, Lara
    De Giorgio, Roberto
    Stanghellini, Vincenzo
    Corinaldesi, Roberto
    GASTROENTEROLOGY, 2014, 146 (05) : S124 - S124
  • [18] Effects of a gluten challenge in patients with irritable bowel syndrome: a randomized single-blind controlled clinical trial
    Saeede Saadati
    Amir Sadeghi
    Hamid Mohaghegh-Shalmani
    Mohammad Rostami-Nejad
    Luca Elli
    Hamid Asadzadeh-Aghdaei
    Luis Rodrigo
    Mohammad Reza Zali
    Scientific Reports, 12
  • [19] Effects of a gluten challenge in patients with irritable bowel syndrome: a randomized single-blind controlled clinical trial
    Saadati, Saeede
    Sadeghi, Amir
    Mohaghegh-Shalmani, Hamid
    Rostami-Nejad, Mohammad
    Elli, Luca
    Asadzadeh-Aghdaei, Hamid
    Rodrigo, Luis
    Zali, Mohammad Reza
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [20] Placebos without Deception: A Randomized Controlled Trial in Irritable Bowel Syndrome
    Kaptchuk, Ted J.
    Friedlander, Elizabeth
    Kelley, John M.
    Sanchez, M. Norma
    Kokkotou, Efi
    Singer, Joyce P.
    Kowalczykowski, Magda
    Miller, Franklin G.
    Kirsch, Irving
    Lembo, Anthony J.
    PLOS ONE, 2010, 5 (12):